Bixiye
BC-COM-PharmProgPolicyNotifctn-Eff-3.15.22.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1761 - 1770 ee natiijooyinka 3563
Bixiye
P5-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P6-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P8-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
QP45-22 First Responder Mental Health Summit: Clinician Awareness Course Friday, June 24
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
Project name:
Bixiye
QP36-22 Commercial Pharmacy Benefit Exclusion for Xolair®
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP37-22 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: VoxzogoTM (vosoritide)
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022